These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 6104580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ, Duncan AE, Delauna FA, Hucker HB, Gruber VF, Vandenheuvel WJ.
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [Abstract] [Full Text] [Related]

  • 3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 4. Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.
    Tocco DJ, deLuna FA, Duncan AE, Walker RW, Arison BH, Vandenheuvel WJ.
    Drug Metab Dispos; 1979 Oct; 7(5):330-4. PubMed ID: 40776
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of labetalol by animals and man.
    Martin LE, Hopkins R, Bland R.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP.
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [Abstract] [Full Text] [Related]

  • 7. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG, Hillbeck D, Hartley TE, Gilbert PJ, Coe RA, Troke JA, Vose CW.
    Drug Metab Dispos; 1993 May; 21(6):1037-47. PubMed ID: 7905382
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D, Siefert HM, Weber H, Rämsch K, Suwelack D.
    Arzneimittelforschung; 1985 May; 35(12):1781-6. PubMed ID: 4096729
    [Abstract] [Full Text] [Related]

  • 9. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK, Woolf EJ, Hoagland VL, Sturgill MG, Deutsch PJ, Yeh KC, Lin JH.
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN, Kraml M, Ferdinandi ES, Greselin E, Dvornik D.
    Drug Metab Rev; 1981 Dec; 12(2):339-62. PubMed ID: 6461537
    [Abstract] [Full Text] [Related]

  • 12. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG, John BA, Chasseaud LF, Bonn R, Grote H, Sandrock K, Darragh A, Lambe RF.
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [Abstract] [Full Text] [Related]

  • 13. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
    Denissen JF, Grabowski BA, Johnson MK, Buko AM, Kempf DJ, Thomas SB, Surber BW.
    Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [Abstract] [Full Text] [Related]

  • 15. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W, Erlaçin S, Frankus E, Uragg H.
    Arzneimittelforschung; 1981 Feb; 31(11):1932-43. PubMed ID: 7198474
    [Abstract] [Full Text] [Related]

  • 16. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C, Soliman V.
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.
    Vickers S, Duncan CA, Kari PH, Homnick CF, Elliott JM, Pitzenberger SM, Hichens M, Vyas KP.
    Drug Metab Dispos; 1993 Nov; 21(3):467-73. PubMed ID: 8100503
    [Abstract] [Full Text] [Related]

  • 18. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 19. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys.
    Sasaki H, Kamimura H, Kaniwa H, Kawamura S, Takaichi M, Yokoshima T.
    Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657
    [Abstract] [Full Text] [Related]

  • 20. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
    Zacchei AG, Weidner LL, Besselaar GH, Raftery EB.
    Drug Metab Dispos; 1976 Aug; 4(4):387-401. PubMed ID: 8295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.